Biochemical modulation of fluoropyrimidines: Is there an optimal (6R,S)leucovorin dose and schedule?

Journal of the National Cancer Institute

Volumn 88, Issue 7, 1996, Pages 393-395

  Doroshow, J H ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROPYRIMIDINE DERIVATIVE; FLUOROURACIL; FOLINIC ACID;

ANTINEOPLASTIC ACTIVITY; COLORECTAL CANCER; DIARRHEA; DOSE RESPONSE; DRUG CYTOTOXICITY; DRUG METABOLISM; EDITORIAL; HUMAN; MUCOSA INFLAMMATION;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; FLOXURIDINE; FLUOROURACIL; HUMANS; LEUCOVORIN;

EID: 0029873191     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/88.7.393     Document Type: Editorial

References (0)